Pooling overdispersed binomial data to estimate event rate

被引:43
作者
Young-Xu, Yinong [1 ]
Chan, K. Arnold [2 ,3 ]
机构
[1] EpiPatterns, Haverhill, NH USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[3] i3 Drug Safety, Waltham, MA USA
关键词
D O I
10.1186/1471-2288-8-58
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The beta-binomial model is one of the methods that can be used to validly combine event rates from overdispersed binomial data. Our objective is to provide a full description of this method and to update and broaden its applications in clinical and public health research. Methods: We describe the statistical theories behind the beta-binomial model and the associated estimation methods. We supply information about statistical software that can provide beta-binomial estimations. Using a published example, we illustrate the application of the beta-binomial model when pooling overdispersed binomial data. Results: In an example regarding the safety of oral antifungal treatments, we had 41 treatment arms with event rates varying from 0% to 13.89%. Using the beta-binomial model, we obtained a summary event rate of 3.44% with a standard error of 0.59%. The parameters of the beta-binomial model took the values of 1.24 for alpha and 34.73 for beta. Conclusion: The beta-binomial model can provide a robust estimate for the summary event rate by pooling overdispersed binomial data from different studies. The explanation of the method and the demonstration of its applications should help researchers incorporate the beta-binomial method as they aggregate probabilities of events from heterogeneous studies.
引用
收藏
页数:12
相关论文
共 66 条
[1]  
Alpsoy Erkan, 1996, Journal of Dermatology (Tokyo), V23, P259, DOI 10.1111/j.1346-8138.1996.tb04009.x
[2]  
Anderson DA., 1988, Aust J Stat, V30, P125, DOI [10.1111/j.1467-842X.1988.tb00844.x, DOI 10.1111/J.1467-842X.1988.TB00844.X]
[3]  
[Anonymous], 1993, DRUG INF J, DOI DOI 10.1177/009286159302700242
[4]  
[Anonymous], J STAT COMPUT SIMUL
[5]  
[Anonymous], 2000, C&H TEXT STAT SCI
[6]   An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis [J].
Arca, E ;
Tastan, HB ;
Akar, A ;
Kurumlu, Z ;
Gür, AR .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2002, 13 (01) :3-9
[7]   OPEN RANDOMIZED COMPARISON OF ITRACONAZOLE VERSUS TERBINAFINE IN ONYCHOMYCOSIS [J].
ARENAS, R ;
DOMINGUEZCHERIT, J ;
FERNANDEZ, LMA .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1995, 34 (02) :138-143
[8]   Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis [J].
Avner, S ;
Nir, N ;
Henri, T .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2005, 16 (5-6) :327-330
[9]  
Baldari U., 2000, Giornale Italiano di Dermatologia e Venereologia, V135, P229
[10]   A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region [J].
Baran, R ;
Feuilhade, M ;
Datry, A ;
Goettmann, S ;
Pietrini, P ;
Viguie, C ;
Badillet, G ;
Larnier, C ;
Czernielewski, J .
BRITISH JOURNAL OF DERMATOLOGY, 2000, 142 (06) :1177-1183